Patent · US Active

Modified factor X polypeptides and uses thereof

US9856467B2 · kind B2 · utility

0Cited by

29References

35Claims

0Family size

Assignee

Catalyst Biosciences, Inc. · US

Inventors

Edwin L. Madison · Dallas, US
Christopher D. Thanos · Tiburon, US

Key dates

Filing date	Apr 3, 2014
Grant date	Jan 2, 2018
Priority date	—
Expiry date	Apr 3, 2034

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P7/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified therapeutic proteins are provided. In particular modified Factor X polypeptides, which includes the Factor X zymogen, Factor Xa and other forms of Factor X, and uses thereof are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.